Cargando…
Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation
PURPOSE: Chemoradiation (CRT) is a definitive treatment option for muscle-invasive bladder cancer (MIBC). Despite its effectiveness, CRT is underused, in part owing to concerns of tolerability and the need for integrated multidisciplinary care. We investigated factors associated with and the impact...
Autores principales: | Kotha, Nikhil V., Kumar, Abhishek, Nelson, Tyler J., Qiao, Edmund M., Qian, Alex S., Voora, Rohith S., McKay, Rana R., Stewart, Tyler F., Rose, Brent S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767252/ https://www.ncbi.nlm.nih.gov/pubmed/35071834 http://dx.doi.org/10.1016/j.adro.2021.100836 |
Ejemplares similares
-
Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer
por: Kotha, Nikhil V., et al.
Publicado: (2022) -
Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in
Advanced Larynx Cancer
por: Kotha, Nikhil V, et al.
Publicado: (2021) -
Evaluating the clinical trends and benefits of low‐dose computed tomography in lung cancer patients
por: Qiao, Edmund M., et al.
Publicado: (2021) -
Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021) -
Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System
por: Qiao, Edmund M., et al.
Publicado: (2022)